lam-002

1 stories · following the connections

Business

LAM Therapeutics Announces Progress of its Clinical Portfolio with FDA Clearance of New Trial in Leukemia and Advancement of Clinical Trial in Lymphoma

By Nasdaq OMXNov 30, 2017, 6:00 AM UTC